Earnings Call Summary | Atomera(ATOM.US) Q1 2024 Earnings Conference
Earnings Call Summary | Atomera(ATOM.US) Q1 2024 Earnings Conference
The following is a summary of the Atomera Incorporated (ATOM) Q1 2024 Earnings Call Transcript:
以下是Atomera Incorporated（ATOM）2024年第一季度财报电话会议记录的摘要：
Financial Performance:
财务业绩：
Atomera reported a GAAP net loss for Q1 2024 of $4.8 million or $0.19 per share, a slight improvement from a net loss of $5 million in Q1 2023.
Q1 2024 revenues were $18,000, compared to $0 in Q1 2023 and a significant decrease from $550,000 in Q4 2023.
The company maintained a balance of cash, cash equivalents, and short-term investments of $19.3 million at the end of Q1 2024.
Atomera报告称，2024年第一季度的GAAP净亏损为480万美元，合每股亏损0.19美元，较2023年第一季度的500万美元净亏损略有改善。
2024年第一季度的收入为18,000美元，而2023年第一季度为0美元，较2023年第四季度的55万美元大幅下降。
截至2024年第一季度末，该公司的现金、现金等价物和短期投资余额维持在1,930万美元。
Business Progress:
业务进展：
Development of Atomera's MST technology with STMicroelectronics is on track for production release.
The company has increased submissions for licenses and JDAs, increasing potential for new contracts and partnerships.
Atomera's partnership with the JDA2 customer shows promising early data that could lead to a licensing agreement and production.
The company is expanding its portfolio with new variations of silicon lattice films and is securing patents around structures in advanced nodes and memory area.
Atomera is actively involved with manufacturers in the RF SOI market and has made their MST CAD tools available for customers.
The company is exploring the GaN and compound semiconductor markets for new potential revenue streams.
与意法半导体共同开发的Atomera的MST技术有望量产发布。
该公司增加了许可证和JDA的申请，增加了签订新合同和合作伙伴关系的可能性。
Atomera与JDA2客户的合作显示出令人鼓舞的早期数据，这些数据可能会导致许可协议和生产。
该公司正在通过硅晶格薄膜的新变体来扩大其产品组合，并正在获得有关先进节点和存储区域结构的专利。
Atomera积极参与射频SOI市场的制造商的合作，并已向客户提供了他们的MST CAD工具。
该公司正在探索氮化镓和化合物半导体市场，寻找新的潜在收入来源。
More details: Atomera IR
更多详情： Atomera 红外
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多详情，请访问投资者关系网站。本文仅供投资者参考，不构成任何投资建议。
译文内容由第三方软件翻译。